Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Rare Disease Diagnostics Market Segmentation
1.Executive Summary
2.Global Rare Disease Diagnostics Market Introduction
2.1.Global Rare Disease Diagnostics Market - Taxonomy
2.2.Global Rare Disease Diagnostics Market - Definitions
2.2.1.By Product Type
2.2.2.By Trait Type
2.2.3.By Disease Type
2.2.4.By Test Type
2.2.5.By Region
3.Global Rare Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
4.Global Rare Disease Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5.Global Rare Disease Diagnostics Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Kits and Assays
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Panels
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6.Global Rare Disease Diagnostics Market By Trait Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Inherited Trait
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Acquired Trait
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7.Global Rare Disease Diagnostics Market By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Gastroenterology Disease
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Endocrine and Metabolism Disorders Disease
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Neurology Disease
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Hematology and Oncology Disease
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Dermatology Disease
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Others
7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8.Global Rare Disease Diagnostics Market By Test Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Genetic Test
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. General Lab Test
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Imaging Test
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9.Global Rare Disease Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
10.North America Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1.Kits and Assays
10.1.2.Panels
10.1.3.Others
10.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1.Inherited Trait
10.2.2.Acquired Trait
10.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1.Gastroenterology Disease
10.3.2.Endocrine and Metabolism Disorders Disease
10.3.3.Cardiovascular Disorders
10.3.4.Neurology Disease
10.3.5.Hematology and Oncology Disease
10.3.6.Dermatology Disease
10.3.7.Others
10.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1.Genetic Test
10.4.2.General Lab Test
10.4.3.Imaging Test
10.4.4.Others
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1.Kits and Assays
11.1.2.Panels
11.1.3.Others
11.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1.Inherited Trait
11.2.2.Acquired Trait
10.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1.Gastroenterology Disease
11.3.2.Endocrine and Metabolism Disorders Disease
11.3.3.Cardiovascular Disorders
11.3.4.Neurology Disease
11.3.5.Hematology and Oncology Disease
11.3.6.Dermatology Disease
11.3.7.Others
11.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1.Genetic Test
11.4.2.General Lab Test
11.4.3.Imaging Test
11.4.4.Others
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1.Kits and Assays
12.1.2.Panels
12.1.3.Others
12.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1.Inherited Trait
12.2.2.Acquired Trait
11.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1.Gastroenterology Disease
12.3.2.Endocrine and Metabolism Disorders Disease
12.3.3.Cardiovascular Disorders
12.3.4.Neurology Disease
12.3.5.Hematology and Oncology Disease
12.3.6.Dermatology Disease
12.3.7.Others
12.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1.Genetic Test
12.4.2.General Lab Test
12.4.3.Imaging Test
12.4.4.Others
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Latin America Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1.Kits and Assays
13.1.2.Panels
13.1.3.Others
13.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1.Inherited Trait
13.2.2.Acquired Trait
12.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1.Gastroenterology Disease
13.3.2.Endocrine and Metabolism Disorders Disease
13.3.3.Cardiovascular Disorders
13.3.4.Neurology Disease
13.3.5.Hematology and Oncology Disease
13.3.6.Dermatology Disease
13.3.7.Others
13.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1.Genetic Test
13.4.2.General Lab Test
13.4.3.Imaging Test
13.4.4.Others
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1.Brazil
13.5.2.Mexico
13.5.3.Rest of LA
14.Middle East and Africa Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.1.1.Kits and Assays
14.1.2.Panels
14.1.3.Others
14.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.2.1.Inherited Trait
14.2.2.Acquired Trait
13.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.3.1.Gastroenterology Disease
14.3.2.Endocrine and Metabolism Disorders Disease
14.3.3.Cardiovascular Disorders
14.3.4.Neurology Disease
14.3.5.Hematology and Oncology Disease
14.3.6.Dermatology Disease
14.3.7.Others
14.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.4.1.Genetic Test
14.4.2.General Lab Test
14.4.3.Imaging Test
14.4.4.Others
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.5.1.GCC Countries
14.5.2.South Africa
14.5.3.Rest of MEA
15. Competition Landscape
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)
15.2.1.Quest Diagnostics Incorporated
15.2.2.Centogene NV
15.2.3.Invitae Corporation
15.2.4.3billion Inc.
15.2.5.ARUP Laboratories
15.2.6.Eurofins Scientific Inc.
15.2.7.Strand Life Sciences Private Limited
15.2.8.Ambry Genetics Corporations
15.2.9.PerkinElmer Genetics Inc.
15.2.10.Macrogen Inc.
15.2.11.Baylor Miraca Genetics Laboratories, LLC
15.2.12.Color Health Inc.
15.2.13.Beijing Genomics Institute Ltd
16. Research Methodology
17. Appendix and Abbreviations
2.Global Rare Disease Diagnostics Market Introduction
2.1.Global Rare Disease Diagnostics Market - Taxonomy
2.2.Global Rare Disease Diagnostics Market - Definitions
2.2.1.By Product Type
2.2.2.By Trait Type
2.2.3.By Disease Type
2.2.4.By Test Type
2.2.5.By Region
3.Global Rare Disease Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
4.Global Rare Disease Diagnostics Market Analysis, 2018-2022 and Forecast 2023-2029
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5.Global Rare Disease Diagnostics Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Kits and Assays
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Panels
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Others
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6.Global Rare Disease Diagnostics Market By Trait Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Inherited Trait
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Acquired Trait
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7.Global Rare Disease Diagnostics Market By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Gastroenterology Disease
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Endocrine and Metabolism Disorders Disease
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Cardiovascular Disorders
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Neurology Disease
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Hematology and Oncology Disease
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
7.6. Dermatology Disease
7.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.6.3. Market Opportunity Analysis
7.7. Others
7.7.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.7.3. Market Opportunity Analysis
8.Global Rare Disease Diagnostics Market By Test Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Genetic Test
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. General Lab Test
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Imaging Test
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9.Global Rare Disease Diagnostics Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
10.North America Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.1.1.Kits and Assays
10.1.2.Panels
10.1.3.Others
10.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.2.1.Inherited Trait
10.2.2.Acquired Trait
10.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.3.1.Gastroenterology Disease
10.3.2.Endocrine and Metabolism Disorders Disease
10.3.3.Cardiovascular Disorders
10.3.4.Neurology Disease
10.3.5.Hematology and Oncology Disease
10.3.6.Dermatology Disease
10.3.7.Others
10.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.4.1.Genetic Test
10.4.2.General Lab Test
10.4.3.Imaging Test
10.4.4.Others
10.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.1.1.Kits and Assays
11.1.2.Panels
11.1.3.Others
11.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.2.1.Inherited Trait
11.2.2.Acquired Trait
10.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.3.1.Gastroenterology Disease
11.3.2.Endocrine and Metabolism Disorders Disease
11.3.3.Cardiovascular Disorders
11.3.4.Neurology Disease
11.3.5.Hematology and Oncology Disease
11.3.6.Dermatology Disease
11.3.7.Others
11.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.4.1.Genetic Test
11.4.2.General Lab Test
11.4.3.Imaging Test
11.4.4.Others
11.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.1.1.Kits and Assays
12.1.2.Panels
12.1.3.Others
12.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.2.1.Inherited Trait
12.2.2.Acquired Trait
11.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.3.1.Gastroenterology Disease
12.3.2.Endocrine and Metabolism Disorders Disease
12.3.3.Cardiovascular Disorders
12.3.4.Neurology Disease
12.3.5.Hematology and Oncology Disease
12.3.6.Dermatology Disease
12.3.7.Others
12.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.4.1.Genetic Test
12.4.2.General Lab Test
12.4.3.Imaging Test
12.4.4.Others
12.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Latin America Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.1.1.Kits and Assays
13.1.2.Panels
13.1.3.Others
13.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.2.1.Inherited Trait
13.2.2.Acquired Trait
12.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.3.1.Gastroenterology Disease
13.3.2.Endocrine and Metabolism Disorders Disease
13.3.3.Cardiovascular Disorders
13.3.4.Neurology Disease
13.3.5.Hematology and Oncology Disease
13.3.6.Dermatology Disease
13.3.7.Others
13.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.4.1.Genetic Test
13.4.2.General Lab Test
13.4.3.Imaging Test
13.4.4.Others
13.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
13.5.1.Brazil
13.5.2.Mexico
13.5.3.Rest of LA
14.Middle East and Africa Rare Disease Diagnostics Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.1.1.Kits and Assays
14.1.2.Panels
14.1.3.Others
14.2. Trait Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.2.1.Inherited Trait
14.2.2.Acquired Trait
13.3. Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.3.1.Gastroenterology Disease
14.3.2.Endocrine and Metabolism Disorders Disease
14.3.3.Cardiovascular Disorders
14.3.4.Neurology Disease
14.3.5.Hematology and Oncology Disease
14.3.6.Dermatology Disease
14.3.7.Others
14.4. Test Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.4.1.Genetic Test
14.4.2.General Lab Test
14.4.3.Imaging Test
14.4.4.Others
14.5. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)
14.5.1.GCC Countries
14.5.2.South Africa
14.5.3.Rest of MEA
15. Competition Landscape
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)
15.2.1.Quest Diagnostics Incorporated
15.2.2.Centogene NV
15.2.3.Invitae Corporation
15.2.4.3billion Inc.
15.2.5.ARUP Laboratories
15.2.6.Eurofins Scientific Inc.
15.2.7.Strand Life Sciences Private Limited
15.2.8.Ambry Genetics Corporations
15.2.9.PerkinElmer Genetics Inc.
15.2.10.Macrogen Inc.
15.2.11.Baylor Miraca Genetics Laboratories, LLC
15.2.12.Color Health Inc.
15.2.13.Beijing Genomics Institute Ltd
16. Research Methodology
17. Appendix and Abbreviations
• Quest Diagnostics Incorporated
• Centogene NV
• Invitae Corporation
• 3billion Inc.
• ARUP Laboratories
• Eurofins Scientific Inc.
• Strand Life Sciences Private Limited
• Ambry Genetics Corporations
• PerkinElmer Genetics Inc.
• Macrogen Inc.
• Baylor Miraca Genetics Laboratories, LLC
• Color Health Inc.
• Beijing Genomics Institute Ltd
• Centogene NV
• Invitae Corporation
• 3billion Inc.
• ARUP Laboratories
• Eurofins Scientific Inc.
• Strand Life Sciences Private Limited
• Ambry Genetics Corporations
• PerkinElmer Genetics Inc.
• Macrogen Inc.
• Baylor Miraca Genetics Laboratories, LLC
• Color Health Inc.
• Beijing Genomics Institute Ltd